title: Cytokines in acute myocardial infarction: selective increase in circulating tumor necrosis factor, its soluble receptor, and interleukin-1 receptor antagonist.
abstract: Cytokines play a pathogenetic role in a variety of infective and inflammatory diseases. In the present study, we had two objectives: (a) to define the kinetics of tumor necrosis factor (TNF) in plasma after acute myocardial infarction (AMI) in patients treated with early thrombolysis, and (b) to measure other cytokines, interleukin-1 (IL-1) and TNF receptor antagonists, in plasma. TNF-alpha, but not IL-1 beta or IL-8, was present in plasma of 6 of 7 patients with severe AMI (Killip class 3 or 4). No TNF (< 50 pg/ml) was detected in a group of 11 patients with uncomplicated myocardial infarction (Killip class 1) or in control patients without AMI. Soluble TNF receptor type I and IL-1 receptor antagonist (IL-1Ra) were also significantly increased in the group with severe AMI compared with those with uncomplicated AMI. Circulating TNF is increased only in AMI complicated by heart failure at hospital admission. This finding may have diagnostic and therapeutic relevance.
authors.affiliation: Mario Negri Institute for Pharmacological Research, Milan, Italy.
authors.forename: R
authors.initials: R
authors.lastname: Latini
authors.forename: M
authors.initials: M
authors.lastname: Bianchi
authors.forename: E
authors.initials: E
authors.lastname: Correale
authors.forename: C A
authors.initials: CA
authors.lastname: Dinarello
authors.forename: G
authors.initials: G
authors.lastname: Fantuzzi
authors.forename: C
authors.initials: C
authors.lastname: Fresco
authors.forename: A P
authors.initials: AP
authors.lastname: Maggioni
authors.forename: M
authors.initials: M
authors.lastname: Mengozzi
authors.forename: S
authors.initials: S
authors.lastname: Romano
authors.forename: L
authors.initials: L
authors.lastname: Shapiro
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D005260:Female; D006801:Humans; D053590:Interleukin 1 Receptor Antagonist Protein; D007375:Interleukin-1 / Q000097:blood; D016209:Interleukin-8 / Q000097:blood; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000097:blood* / Q000188:drug therapy; D018124:Receptors, Tumor Necrosis Factor / Q000037:antagonists & inhibitors*; D011994:Recombinant Proteins / Q000627:therapeutic use; D012795:Sialoglycoproteins / Q000097:blood*; D013300:Streptokinase / Q000627:therapeutic use; D010959:Tissue Plasminogen Activator / Q000627:therapeutic use; D014409:Tumor Necrosis Factor-alpha / Q000378:metabolism*
chemical_list: C507763:IL1RN protein, human; D053590:Interleukin 1 Receptor Antagonist Protein; D007375:Interleukin-1; D016209:Interleukin-8; D018124:Receptors, Tumor Necrosis Factor; D011994:Recombinant Proteins; D012795:Sialoglycoproteins; D014409:Tumor Necrosis Factor-alpha; D013300:Streptokinase; D010959:Tissue Plasminogen Activator